FMC Corporation completes sale of peroxygens business to One Equity Partners

Date:03-04-2014

FMC Corporation recently announced the company has completed the sale of its Peroxygens business to affiliates of One Equity Partners, the private investment arm of J.P. Morgan Chase & Co., for approximately $200 million.

"We're pleased that our former Peroxygens business is now in the capable hands of One Equity Partners where it can grow with focused attention and investment," said Pierre Brondeau, FMC president, CEO and chairman. "This transaction allows FMC to direct its resources to core businesses and its portfolio of advanced technologies."